PX1 Research supplies USA-manufactured TB4 peptide engineered exclusively for in vitro and preclinical research applications. Every batch undergoes rigorous RP-HPLC purity testing and LC-MS mass identity verification to ensure maximum experimental reproducibility across laboratory models.
PX1 Research supplies USA-manufactured TB4 peptide engineered exclusively for in vitro and preclinical research applications. Every batch undergoes rigorous RP-HPLC purity testing and LC-MS mass identity verification to ensure maximum experimental reproducibility across laboratory models.
When evaluating where to buy TB4 peptide for laboratory research, investigators must select suppliers providing verified purity and analytical transparency. PX1 Research offers USA-synthesized Thymosin Beta-4 (TB4) tested via RP-HPLC and LC-MS. Every lot includes a third-party Certificate of Analysis, ensuring sequence fidelity and low endotoxin levels for preclinical assays.
Thymosin Beta-4 (TB4) is a naturally occurring 43-amino-acid peptide that serves as the primary G-actin sequestering molecule in eukaryotic cells. Within cellular biology research, TB4 is widely investigated for its pivotal role in cytoskeletal organization, cell migration, tissue remodeling, and anti-inflammatory signaling cascades. For researchers seeking consistent baseline data, securing chemical purity above 98% is critical to prevent residual synthetic byproducts from confounding assay readouts.
At PX1 Research, our catalog of research peptides is manufactured under strict quality standards within US-based facilities. We prioritize batch-to-batch consistency by subjecting every lot to independent ISO 17025 accredited laboratory verification. Research teams purchasing our TB-500 / Thymosin Beta-4 research peptide receive complete documentation detailing identity, sequence confirmation, and purity profiles prior to initiating experiments.
Thymosin Beta-4 is an acidic, highly conserved peptide with a molecular weight of approximately 4,963 Da. Its primary sequence—Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH—contains the central actin-binding motif LKKTET. This specific hexapeptide sequence facilitates the reversible binding of monomeric globular actin (G-actin) in a 1:1 stoichiometry.
By sequestering G-actin monomers, TB4 maintains a dynamic intracellular pool of unpolymerized actin necessary for rapid cellular remodeling. When extracellular signals trigger cell movement, TB4 releases G-actin, allowing rapid assembly into filamentous actin (F-actin). In vitro experiments demonstrate that this regulation is essential for endothelial cell motility, lamellipodia formation, and focal adhesion dynamics during cellular migration assays.
Detailed research into the Thymosin Beta-4 molecular mechanism indicates that TB4 also modulates localized gene expression. Preclinical studies suggest that extracellular TB4 can enter cells via low-affinity endocytic pathways or engage specific cell-surface complexes, down-regulating nuclear factor kappa B (NF-κB) transcription factors and reducing pro-inflammatory cytokine expression such as TNF-α and IL-1β.
In preclinical animal models, TB4 has demonstrated multi-faceted activity in tissue regeneration, neovascularization, and cytoprotection. Rodent studies evaluating dermal wound healing indicate that topical or systemic administration of TB4 accelerates re-epithelialization and collagen deposition. The compound promotes the migration of keratinocytes and endothelial cells into damaged tissue beds without inducing systemic toxicity.
Angiogenesis is another primary area of preclinical investigation. In vitro tubulogenesis assays using human umbilical vein endothelial cells (HUVECs) show that TB4 stimulates capillary-like tube formation. This effect is mediated in part through the up-regulation of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs), which break down extracellular matrix components to allow microvascular sprouting.
Furthermore, cardioprotective and neuroprotective models suggest that TB4 preserves cell survival under hypoxic stress. In rodent myocardial ischemia models, administration of TB4 led to reduced cardiomyocyte apoptosis and decreased scar formation. Researchers utilizing our research library hub can access additional literature on how TB4 interacts with survival kinases such as Akt/PKB to promote cell survival in oxidative stress assays.
When designing tissue repair and cytoprotection protocols, investigators frequently compare TB4 with other prominent synthetic peptides. While TB4 acts primarily through actin sequestration and endothelial cell recruitment, compounds such as BPC-157 research peptide work through distinct signaling axes, including nitric oxide pathway modulation and early growth response-1 (EGR-1) gene activation. Consequently, research evaluating soft tissue repair often contrasts the cytoplasmic structural activity of TB4 against the gastroprotective and tendon-healing properties of BPC-157.
Similarly, GHK-Cu research peptide functions via copper-chelation dynamics, up-regulating extracellular matrix remodeling genes and decorin synthesis. While GHK-Cu is predominantly studied for dermal remodeling and gene expression modulation, TB4 offers superior influence over actin-driven cell motility and rapid endothelial migration. Another compound targeting inflammatory pathways is KPV research peptide, which acts downstream of alpha-MSH to suppress inflammatory responses.
To better understand the structural and functional differences among these compounds, researchers can consult our detailed technical guide on TB-500 vs BPC-157 in preclinical models. Understanding these divergent pathways allows research teams to select the exact target molecule or combination required for their specific cell culture or animal study paradigms.
Acquiring high-grade peptides requires strict verification of chemical purity and identity. Impurities in synthetic peptides—such as truncated sequences, deletion peptides, or residual trifluoroacetic acid (TFA)—can yield ambiguous assay results or cytotoxicity in sensitive cell lines. Therefore, analytical validation via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Liquid Chromatography-Mass Spectrometry (LC-MS) is mandatory.
RP-HPLC evaluates chromatographic purity by separating the primary peptide peak from synthesis artifacts. PX1 Research enforces a baseline requirement of ≥98% purity (with many lots exceeding 99%) across all custom and catalog peptides. Complementing HPLC, LC-MS confirms the exact molecular mass of the peptide fragment, verifying that the synthesised chain matches the theoretical mass of 4,963.5 Da for TB4.
Endotoxin testing is equally critical for cell culture and in vivo animal models. Bacterial lipopolysaccharides (LPS) can activate Toll-like receptors (TLRs), triggering unwanted immune cascades that corrupt experimental results. PX1 Research subjects all peptide lots to Chromogenic Reagent Limulus Amebocyte Lysate (LAL) testing, guaranteeing endotoxin levels below stringent threshold limits (<0.01 EU/mg).
Proper reconstitution techniques are required to preserve the tertiary structure and bioactivity of lyophilized peptides. TB4 is highly soluble in aqueous media due to its hydrophilic amino acid composition. For general in vitro applications, sterile bacteriostatic water or phosphate-buffered saline (PBS, pH 7.4) is typically recommended as the primary solvent.
When reconstituting TB4, researchers should follow strict aseptic procedures inside a laminar flow hood. Solvent should be added down the side of the glass vial rather than sprayed directly onto the lyophilized cake. Gentle swirl motion should be employed to dissolve the powder completely; vigorous vortexing or agitation must be avoided, as shear forces can cause protein denaturing or aggregate formation.
To achieve target working concentrations, researchers can reference our interactive peptide reconstitution calculator. This tool helps calculate stock concentration, diluent volumes, and aliquot partitioning to minimize freeze-thaw degradation during multi-week experimental series.
Lyophilized TB4 peptide exhibits excellent long-term stability when stored under proper environmental conditions. Vials should be kept desiccated at -20°C for short-to-medium term storage (up to 12 months) or at -80°C for extended archival preservation. Protecting the lyophilized powder from light and moisture ingress prevents premature peptide degradation.
Once reconstituted into aqueous solution, the shelf life of TB4 decreases significantly. Reconstituted stock solutions prepared with sterile, preservative-containing solvents (such as 0.9% benzyl alcohol) remain stable at 2°C to 8°C for up to 28 days. If reconstituted in plain sterile saline or PBS without preservatives, solution aliquots should be used within 24 to 48 hours to eliminate bacterial proliferation risks.
Repeated freeze-thaw cycles lead to peptide aggregation, peptide bond cleavage, and loss of concentration uniformity. Researchers are advised to partition reconstituted stock solutions into single-use micro-centrifuge aliquots before freezing at -20°C or lower. Aliquots should be thawed slowly on ice immediately prior to introduction into assay media.
Selecting a reliable peptide supplier requires scrutinizing manufacturing credentials and quality control procedures. Overseas suppliers frequently offer low-cost products that lack batch traceability, ISO certification, or accurate purity documentation. In contrast, domestic US vendors operate under standardized quality management systems that prioritize compliance and chemical fidelity.
PX1 Research manufactures peptides in state-of-the-art facilities compliant with Good Manufacturing Practice (GMP) standards. Every batch is assigned a unique lot number linked directly to its corresponding analytical documentation. Researchers can review independent, third-party Certificates of Analysis directly on our platform, providing complete transparency into HPLC chromatograms and mass spectra.
Furthermore, academic institutions and corporate laboratories requiring high volume or ongoing supply can set up custom procurement structures through our wholesale lab account portal. Work with dedicated scientific account representatives to secure bulk lot reservations and customized analytical testing suites tailored to specific protocol parameters.
In laboratory research settings, TB4 is utilized across diverse experimental models to evaluate cellular responses to injury and stress. A standard model involves scratch wound assays using cultured dermal fibroblasts or keratinocytes. In these assays, the addition of research-grade TB4 to culture media allows quantitative measurement of cell migration rates, directional motility, and gap closure velocity over 24- to 48-hour periods.
In inflammatory models, researchers measure the ability of TB4 to attenuate inflammatory mediator release in LPS-stimulated macrophages. By quantifying alterations in gene expression via RT-qPCR and protein secretion via ELISA, investigators observe changes in IL-6, TNF-α, and COX-2 levels. These studies elucidate how actin sequestration modulates intracellular signaling cascades linked to systemic inflammation.
Advanced organoid and 3D tissue models also leverage TB4 to study extracellular matrix assembly and angiogenesis. The inclusion of high-purity TB4 in matrigel assays provides insights into vessel branching morphogenesis and pericyte recruitment, serving as a vital control in vascular biology research.
PX1 Research streamlines the procurement process for academic labs, biotechnology firms, and institutional research facilities. We maintain dual distribution centers in California and Arizona to facilitate rapid domestic transit. Orders placed before 3:00 PM EST Monday through Friday are processed for same-day dispatch, ensuring cold-chain integrity and minimizing transit delays.
All products are shipped in temperature-stable packaging engineered to insulate lyophilized peptides against environmental temperature fluctuations. Researchers purchasing our research-grade TB4 peptide receive vacuum-sealed, tamper-evident vials accompanied by comprehensive safety data sheets (SDS) and storage instructions.
For teams conducting multi-phase studies or high-throughput screens, securing standardized single-lot batches ensures longitudinal reproducibility. Explore our full catalog of research compounds or consult our scientific support team to discuss specialized handling, custom synthesis, or bulk procurement options.
What is the primary mechanism of action of TB4 peptide in laboratory models?
Thymosin Beta-4 (TB4) functions primarily by sequestering monomeric G-actin in a 1:1 binding ratio via its central LKKTET amino acid sequence. This maintains a dynamic intracellular pool of unpolymerized actin, facilitating rapid filament assembly, cell migration, endothelial sprouting, and cytoskeletal remodeling in cell culture and preclinical models.
How is TB4 peptide purity verified by PX1 Research?
PX1 Research verifies TB4 purity using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm chromatographic purity >98%. Liquid Chromatography-Mass Spectrometry (LC-MS) is performed to verify molecular weight identity (4,963.5 Da), and LAL chromogenic assays ensure endotoxin levels remain below 0.01 EU/mg.
Is TB4 peptide supplied for human administration or clinical use?
No. All peptides supplied by PX1 Research, including TB4, are engineered strictly for laboratory research, in vitro assays, and preclinical animal models. They are not for human or veterinary consumption, therapy, injection, or diagnostic use.
What solvent is recommended for reconstituting TB4 peptide for lab assays?
TB4 is typically reconstituted using sterile bacteriostatic water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the downstream assay. Solvent should be added gently along the vial wall without aggressive vortexing.
What are the recommended storage parameters for lyophilized and reconstituted TB4?
Lyophilized TB4 should be stored desiccated at -20°C for short-to-medium term stability, or at -80°C for long-term storage. Once reconstituted, liquid solutions should be kept at 2°C to 8°C and used within 28 days if preserved, or partitioned into single-use aliquots and frozen at -20°C to prevent freeze-thaw degradation.
How does TB4 differ structurally and functionally from BPC-157?
TB4 is a 43-amino-acid actin-sequestering peptide focused on cytoskeletal dynamics, cell migration, and endothelial vessel formation. BPC-157 is a 15-amino-acid synthetic fragment derived from gastric juice protein, primarily studied for its effects on nitric oxide signaling, tendon-to-bone healing, and focal adhesion kinase pathways.
Where are PX1 Research peptides manufactured and shipped from?
PX1 Research peptides are synthesized in USA-based, GMP-compliant facilities. Orders are fulfilled and shipped directly from our primary distribution hubs located in California and Arizona, offering same-day dispatch for orders placed Monday through Friday before 3:00 PM EST.
Can research institutions request lot-specific Certificate of Analysis (COA) documents?
Yes. Every batch of TB4 peptide is accompanied by a lot-specific Certificate of Analysis generated by an independent ISO 17025 accredited laboratory, detailing RP-HPLC chromatograms, mass spectrum analysis, and endotoxin assay results.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.